Cargando…
Identification of a BAZ2A-Bromodomain Hit Compound by Fragment Growing
[Image: see text] BAZ2A is an epigenetic regulator affecting transcription of ribosomal RNA. It is overexpressed in aggressive and recurrent prostate cancer, promoting cellular migration. Its bromodomain is characterized by a shallow and difficult-to-drug pocket. Here, we describe a structure-based...
Autores principales: | Dalle Vedove, Andrea, Cazzanelli, Giulia, Batiste, Laurent, Marchand, Jean-Rémy, Spiliotopoulos, Dimitrios, Corsi, Jessica, D’Agostino, Vito Giuseppe, Caflisch, Amedeo, Lolli, Graziano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465710/ https://www.ncbi.nlm.nih.gov/pubmed/36105334 http://dx.doi.org/10.1021/acsmedchemlett.2c00173 |
Ejemplares similares
-
Identification of a BAZ2A Bromodomain Hit Compound
by Fragment Joining
por: Dalle Vedove, Andrea, et al.
Publicado: (2021) -
Reevaluation of bromodomain ligands targeting BAZ2A
por: Cazzanelli, Giulia, et al.
Publicado: (2023) -
Chemical Space Expansion of Bromodomain Ligands Guided
by in Silico Virtual Couplings (AutoCouple)
por: Batiste, Laurent, et al.
Publicado: (2018) -
Targeting Low-Druggability
Bromodomains: Fragment
Based Screening and Inhibitor Design against the BAZ2B Bromodomain
por: Ferguson, Fleur M., et al.
Publicado: (2013) -
Structure Enabled Design of
BAZ2-ICR, A Chemical Probe
Targeting the Bromodomains of BAZ2A and BAZ2B
por: Drouin, Ludovic, et al.
Publicado: (2015)